The Company is a Taiwan-based company primarily engaged in the drug development business. The Company s products and services are mainly new drug development and sales, contract development and manufacturing services, testing services and other services.
The Company s cellular products are categorized into allogeneic mesenchymal stem cell drugs and autologous cell medical technology development cellular products. The Company is also engaged in the provision of aseptic filling services, Good Tissue Practice (GTP) laboratory setup and quality documentation counseling services, and laboratory information management systems. The Company sells its products and services primarily domestically.
History
The Company was established on June 12, 2019.The Company listed on Public Companies of Taiwan Stock Exchange on August 30, 2023.The Company listed on Emerging Stocks of Taiwan Stock Exchange on September 7, 2023.
总部
6 F., No. 1490, Chunri Rd, Taoyuan Dist
桃园市; 桃园市;
联系方式: 购买Hexun Biosciences Co. Ltd.报告以查看信息。
EMIS公司简介是一个更大的信息服务的一部分，它结合了公司，行业和国家数据和分析在超过125个新兴市场.
请求EMIS服务的演示查看更多信息, 申请试用